Sean W Fanning

17PUBLICATIONS
79CO-AUTHORS
Structure and dynamics of materialsBiologically active moleculesBiodiscoveryMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Nov 04, 2026
Native Top-Down Mass Spectrometry Links Structure and Gas-Phase Stability of ERα-LBD.

|Feb 18, 2026
Allosteric Induction of Estrogen Receptor Ligand Binding Domain Tetramerization by a Distinct Complete Estrogen Receptor Antagonist.

Emma C Fink, Reena Chawla, Govinda R Hancock

|Aug 14, 2025
Benzestrol Isomer Stereochemistry Determines the Distinct Estrogenic Activities and Conformations of the Eight Isomers When Bound to Estrogen Receptor α.

Yingwei Hou, Jerome C Nwachukwu, Kathryn Carlson

|Aug 12, 2025
SOX2 utilizes FOXA1 as a heteromeric transcriptional partner to drive proliferation in therapy-resistant prostate cancer.

John T Phoenix, Audris Budreika, Devin A Schmeck

|Jun 16, 2025
Discovery of Palazestrant (OP-1250), a Potent and Orally Bioavailable Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD).

Raymond A Ng, Susanna Barratt, Alison Parisian

|Jun 04, 2025
Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers.

Yanyan Cai, Peihua Zhao, Fan Wu

Pageof 3

Frequent Collaborators

7 joint publications

Geoffrey L Greene

3 joint publications

Emad Tajkhorshid

3 joint publications

Emma Fink

3 joint publications

Sarat Chandarlapaty